Carzomib Injection Substitute
by AYUR
by Others
by Others
by Others
by Others
by Others
by Others
Composition:
CARFILZOMIB-60MG
Uses:
Multiple Myeloma
Medicinal Benefits:
Carfilzomib, a proteasome inhibitor, is present in Carzomib Injection. It suppresses proteasomes, preventing protein breakdown in MM (multiple myeloma) cells. When proteasome function is stopped within the MM cell, a protein build-up occurs within the MM cell, which destroys the malignant cells.
Carzomib Injection contains Carfilzomib, which inhibits proteasomes and thereby prevents protein breakdown in MM (multiple myeloma) cells. When the proteasome action within the MM cell is disturbed, a protein accumulation occurs, destroying the cancerous cells.
No, it is unsafe to father a child while taking Carzomib Injection. It is recommended for sexually active men to use condoms while on treatment and for at least several months after their last dose of Carzomib Injection.
Based on the medical condition, Carzomib Injection may be given alone or together with other medicines used to treat multiple myeloma.
Tell your healthcare professional immediately if you get any signs of an infusion-related reaction during or after the infusion. Your doctor may give other medicines, or the infusion may need to be slowed down or stopped.
Carzomib Injection can cause a significant decrease in the number of blood cells and platelets. Your doctor may suggest laboratory tests before and during the treatment. Tell your healthcare provider if you develop a fever or have signs of bruising or bleeding.